贝达药业：公司经营正常
Betta Pharmaceuticals Co., Ltd.(SZ:300558) Zheng Quan Ri Bao·2026-02-04 13:39Group 1 - The company, BeiGene, stated that its operations are normal and there are no regulatory requirements to issue a performance forecast [2] - The company has scheduled the disclosure of its 2025 annual report for April 23, 2026 [2]